# ILiAD Biotechnologies funding: rounds and investors

> ILiAD Biotechnologies has raised $116M across 2 rounds since 2015. Investors include RA Capital Management, BNP Paribas and Janus Henderson Investors.

Source: https://millionrounds.com/company/iliad-biotechnologies (Millionrounds; every figure on the page links to its filing or article)

United States · [Series D startup](https://millionrounds.com/companies)

# Who invested in *ILiAD Biotechnologies*

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summary Updated 26 Oct 2026

**$116M** raised across 2 rounds since 2015, from 2 sources

**$640K** Venture **$115M** Series D

- **Latest round:** Series D, $115M Feb 2026
- **Step-up i:** 179.7×
- **Investors:** 4

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017 2019 2021 2023 2025

**$640K** Venture

**$115M** Series D

- **First round:** Venture, $640K
- **Biggest round:** $115M
- **Between rounds:** 10.3 years

## The rounds

- **Feb 2026** Series D **$115M** *4 new* [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [BNP Paribas](https://millionrounds.com/fund/bnp-paribas) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases) Source recorded SEC filing: $116M sold, first sale Feb 2026
- **Nov 2015** Venture **$640K** No investor was named in the report. From a historical funding record SEC filing: $640K sold, first sale Oct 2015

## Founders and team

From ILiAD Biotechnologies's own website: 3 on the team.

- **Avi Naider** Board Member
- **James T. Wassil** Board Member
- **Suha Jhaveri** Board Member

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Venture** 2015 **Series D** 2026 [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) [BNP Paribas](https://millionrounds.com/fund/bnp-paribas) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases)

## Everyone who backed them

[RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round

[BNP Paribas](https://millionrounds.com/fund/bnp-paribas) VC firm **1** round

[Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) Private equity **1** round

[National Institute of Allergy and Infectious Diseases](https://millionrounds.com/fund/national-institute-of-allergy-and-infectious-diseases) Investment firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=iliad-biotechnologies).

## Quick answers about ILiAD Biotechnologies

### Who invested in ILiAD Biotechnologies?

ILiAD Biotechnologies's investors include RA Capital Management, BNP Paribas, Janus Henderson Investors and National Institute of Allergy and Infectious Diseases.

### How much has ILiAD Biotechnologies raised?

ILiAD Biotechnologies has raised $116M across 2 rounds since 2015.

### When did ILiAD Biotechnologies last raise?

ILiAD Biotechnologies's most recent round was a Series D of $115M in Feb 2026.

### What was ILiAD Biotechnologies's biggest round?

Its most recent round, $115M in Feb 2026, is also its largest on record.

### Who backed ILiAD Biotechnologies first?

ILiAD Biotechnologies's first round on record, in Feb 2026, was backed by RA Capital Management, BNP Paribas and Janus Henderson Investors and 1 others.

### What stage is ILiAD Biotechnologies at?

ILiAD Biotechnologies's latest named round is a Series D, in Feb 2026.

### Where is ILiAD Biotechnologies based?

ILiAD Biotechnologies is based in the United States.

## Companies like ILiAD Biotechnologies

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app